Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-11

Clinical Trial Update: Prophylactic Effect of Ketorolac Tromethamine on the Cystoid Macular Edema After Phacoemulsification in Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating whether ketorolac tromethamine can prophylax against cystoid macular edema after cataract surgery (phacoemulsification)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACULAR (Ketorolac tromethamine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Cystoid Macular Edema After Phacoemulsification | Phase 2 | Status: UNKNOWN